cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.9632096
title: Closed reference dragonfly prey item data file without any pruning (raw format)

description: Closed reference dragonfly prey item data file without any pruning (raw format). COX1 gene amplification. MiSeq. Data analysed in QIIME
DOI: 10.6084/m9.figshare.9632084
title: Open reference dragonfly gut bacteria data file without any pruning (raw format)

description: Open reference dragonfly gut bacteria data file without any pruning (raw format). MiSeq run data analysed in QIIME
DOI: 10.6084/m9.figshare.9632096.v1
title: Closed reference dragonfly prey item data file without any pruning (raw format)

description: Closed reference dragonfly prey item data file without any pruning (raw format). COX1 gene amplification. MiSeq. Data analysed in QIIME
DOI: 10.6084/m9.figshare.9632075
title: Antimicrobial efficacy of commercially available endodontic bioceramic root canal sealers

description: This table gives insight in all researches of antimicrobial efficacy of commercially available bioceramic root canal sealers , up to June 25,2019.<br>
DOI: 10.6084/m9.figshare.9632072
title: The first <i>Tetralophodon</i> (Mammalia, Proboscidea) cranium from Africa

description: We describe a virtually complete proboscidean cranium and other remains from the late Miocene of Skoura near Ouarzazate, Morocco, assigning them to a derived species of <i>Tetralophodon</i>. African finds of this genus are scarce and are of additional interest due to their potential importance for elephantid phylogeny. The Skoura material adds significantly to the African record of non-anancine tetralophodonts and to the Neogene proboscidean record of northwestern Africa.
DOI: 10.6084/m9.figshare.9632075.v1
title: Antimicrobial efficacy of commercially available endodontic bioceramic root canal sealers

description: This table gives insight in all researches of antimicrobial efficacy of commercially available bioceramic root canal sealers , up to June 25,2019.<br>
DOI: 10.6084/m9.figshare.9632072.v1
title: The first <i>Tetralophodon</i> (Mammalia, Proboscidea) cranium from Africa

description: We describe a virtually complete proboscidean cranium and other remains from the late Miocene of Skoura near Ouarzazate, Morocco, assigning them to a derived species of <i>Tetralophodon</i>. African finds of this genus are scarce and are of additional interest due to their potential importance for elephantid phylogeny. The Skoura material adds significantly to the African record of non-anancine tetralophodonts and to the Neogene proboscidean record of northwestern Africa.
DOI: 10.6084/m9.figshare.9631979
title: MANUSKRIP hasan. Bismillah.docx

description: manuscrip hasan<br>
DOI: 10.6084/m9.figshare.9631910
title: Supplementary Material for: Efficacy, Safety, and Tolerability of Switching from Oral Cholinesterase Inhibitors to Rivastigmine Transdermal Patch with 1-Step Titration in Patients with Mild to Moderate Alzheimer’s Disease: A 24-Week, Open-Label, Multicenter Study in Japan

description: <b><i>Background:</i></b> Few studies have investigated treatment options for patients with Alzheimer’s disease (AD) showing a poor response to oral cholinesterase inhibitors (ChEIs) in Japan. <b><i>Objective:</i></b> To investigate the efficacy and safety of switching from oral ChEIs to rivastigmine transdermal patch in patients with AD. <b><i>Methods:</i></b> In this multicenter, open-label, phase IV study in outpatient clinics in Japan, patients with mild-moderate AD who had a poor response to or experienced difficulty in continuing donepezil or galantamine were switched to rivastigmine transdermal patch (5 cm<sup>2</sup>; loaded dose 9 mg, delivery rate 4.6 mg/24 h) with a 1-step titration in week 4 (10 cm<sup>2</sup>; loaded dose 18 mg, delivery rate 9.5 mg/24 h), which was continued for 4 weeks in the titration period and 16 weeks in a maintenance period. The primary endpoint was the change in Mini-Mental State Examination (MMSE) total score from baseline to week 24. <b><i>Results:</i></b> A total of 118 patients were enrolled and switched to rivastigmine, of which 102 completed the 24-week study. The MMSE total score was essentially unchanged during the study, with a least-square mean change (SD) of −0.35 (2.64) at week 24 (<i>p</i> = 0.1750). Exploratory analysis with a mixed-effect model comparing changes in MMSE between the pre- and post-switch periods suggested that switching to rivastigmine prevented a worsening of MMSE. Application site skin reactions/irritations occurred in 30.5% of patients overall, in 22.0% in the 8-week titration period, and in 10.2% in the 16-week maintenance period. <b><i>Conclusion:</i></b> Within-class switching from an oral ChEI to rivastigmine transdermal patch might be an efficacious and tolerable option for AD patients showing a poor or limited response to a prior oral ChEI.
DOI: 10.6084/m9.figshare.9631907
title: Nothobranchius melanospilus microsatellite markers

description: dataset in Structure format, data used fir Structure analysis (and other population genetic analyses) in the paper Bartáková et al.:<b> Genetic diversity of a widespread annual killifish from coastal Tanzania</b><b></b>
DOI: 10.6084/m9.figshare.9631979.v1
title: MANUSKRIP hasan. Bismillah.docx

description: manuscrip hasan<br>
DOI: 10.6084/m9.figshare.9631901
title: EC9_B53.nwb

description: The enclosed data is collected using a high-density 256-channel electrocorticography array implanted in a human patient during treatment for epilepsy. The subjects are reading aloud consonant-vowel syllables from a list. The data was collected by Dr. Edward Chang at the University of California, San Francisco, and curated by Ben Dichter.<br>Data is organized by subject ID, and each file is a continuous recording session in Neurodata Without Borders: Neurophysiology (NWB:N) 2.0 format. Voltage traces are included for each of the recorded 256 channels. Microphone signal was recorded at the time but is removed for HIPAA compliance. Detailed hand-marked annotations are provided which mark what syllable was said, and the times of the start, consonant-vowel transition, and end of each syllable. A rest-period time is also included when the subject was silent, which can be used as a baseline. Hand-marked anatomical labels are included for electrodes in the relevant brain regions. All dates have been removed for HIPAA compliance and replaced with Jan 1, 1900.
DOI: 10.6084/m9.figshare.9631907.v2
title: Nothobranchius melanospilus microsatellite markers

description: dataset in Structure format, data used fir Structure analysis (and other population genetic analyses) in the paper Bartáková et al.:<b> Genetic diversity of a widespread annual killifish from coastal Tanzania</b><b></b>
DOI: 10.6084/m9.figshare.9631907.v1
title: Nothobranchius melanospilus micro satellites

description: dataset in Structure format, data used fir Structure analysis (and other population genetic analyses) in the paper Bartáková et al.:<b> Genetic diversity of a widespread annual killifish from coastal Tanzania</b><b></b>
DOI: 10.6084/m9.figshare.9631901.v1
title: EC9_B53.nwb

description: The enclosed data is collected using a high-density 256-channel electrocorticography array implanted in a human patient during treatment for epilepsy. The subjects are reading aloud consonant-vowel syllables from a list. The data was collected by Dr. Edward Chang at the University of California, San Francisco, and curated by Ben Dichter.<br>Data is organized by subject ID, and each file is a continuous recording session in Neurodata Without Borders: Neurophysiology (NWB:N) 2.0 format. Voltage traces are included for each of the recorded 256 channels. Microphone signal was recorded at the time but is removed for HIPAA compliance. Detailed hand-marked annotations are provided which mark what syllable was said, and the times of the start, consonant-vowel transition, and end of each syllable. A rest-period time is also included when the subject was silent, which can be used as a baseline. Hand-marked anatomical labels are included for electrodes in the relevant brain regions. All dates have been removed for HIPAA compliance and replaced with Jan 1, 1900.
DOI: 10.6084/m9.figshare.9631883
title: Quantifying the colour loss of green field pea (Pisum sativum L.) due to bleaching

description: This data relates to the manuscript "Quantifying the colour loss of green field pea (Pisum sativum L.) due to bleaching".
DOI: 10.6084/m9.figshare.9631880
title: EC9_B46.nwb

description: The enclosed data is collected using a high-density 256-channel electrocorticography array implanted in a human patient during treatment for epilepsy. The subjects are reading aloud consonant-vowel syllables from a list. The data was collected by Dr. Edward Chang at the University of California, San Francisco, and curated by Ben Dichter.<br>Data is organized by subject ID, and each file is a continuous recording session in Neurodata Without Borders: Neurophysiology (NWB:N) 2.0 format. Voltage traces are included for each of the recorded 256 channels. Microphone signal was recorded at the time but is removed for HIPAA compliance. Detailed hand-marked annotations are provided which mark what syllable was said, and the times of the start, consonant-vowel transition, and end of each syllable. A rest-period time is also included when the subject was silent, which can be used as a baseline. Hand-marked anatomical labels are included for electrodes in the relevant brain regions. All dates have been removed for HIPAA compliance and replaced with Jan 1, 1900.
DOI: 10.6084/m9.figshare.9631883.v1
title: Quantifying the colour loss of green field pea (Pisum sativum L.) due to bleaching

description: This data relates to the manuscript "Quantifying the colour loss of green field pea (Pisum sativum L.) due to bleaching".
DOI: 10.6084/m9.figshare.9631859
title: Additional file 2: of The first genetic map for yellow lupin enables genetic dissection of adaptation traits in an orphan grain legume crop

description: Table S1. Summary table of all the markers used to develop a yellow lupin map. The table comprised of marker name (SNP markers from DArT-seq appears as DArT_SNP, SNP from GBS approach appears as Scaffold and PAV markers appears as DArT-PAV), type (Framework = main skeleton markers, Redundant = exact duplicates of Framework markers and Attached = the markers which were initially not used for mapping because of high segregation distortion or missing values but later connected to closest possible location on map) and the chi-square values (expressed both in chi2 and chip values) which show the deviation from expected 1:1 ratios.Â (XLSX 1258 kb)
DOI: 10.6084/m9.figshare.9631859.v1
title: Additional file 2: of The first genetic map for yellow lupin enables genetic dissection of adaptation traits in an orphan grain legume crop

description: Table S1. Summary table of all the markers used to develop a yellow lupin map. The table comprised of marker name (SNP markers from DArT-seq appears as DArT_SNP, SNP from GBS approach appears as Scaffold and PAV markers appears as DArT-PAV), type (Framework = main skeleton markers, Redundant = exact duplicates of Framework markers and Attached = the markers which were initially not used for mapping because of high segregation distortion or missing values but later connected to closest possible location on map) and the chi-square values (expressed both in chi2 and chip values) which show the deviation from expected 1:1 ratios.Â (XLSX 1258 kb)
DOI: 10.6084/m9.figshare.9631826
title: Additional file 4: of Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

description: Table S4. Baseline characteristics of the patients with ASCVD and at high risks for ASCVD (XLSX 18 kb)
DOI: 10.6084/m9.figshare.9631832
title: Additional file 6: of Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

description: Table S6. Prevalence, cumulative incidence, and incidence density of the risk factors (diabetes, hypertension, and dyslipidemia) for atherosclerotic cardiovascular disease in 2015 (XLSX 17 kb)
DOI: 10.6084/m9.figshare.9631826.v1
title: Additional file 4: of Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

description: Table S4. Baseline characteristics of the patients with ASCVD and at high risks for ASCVD (XLSX 18 kb)
DOI: 10.6084/m9.figshare.9631829
title: Additional file 5: of Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

description: Table S5. Prevalence, cumulative incidence, and incidence density of ASCVD in 2014 and 2015 (XLSX 39 kb)
DOI: 10.6084/m9.figshare.9631829.v1
title: Additional file 5: of Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

description: Table S5. Prevalence, cumulative incidence, and incidence density of ASCVD in 2014 and 2015 (XLSX 39 kb)
DOI: 10.6084/m9.figshare.9631820
title: Additional file 3: of Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

description: Table S3. Medication codes to identify dyslipidemia (XLSX 11 kb)
DOI: 10.6084/m9.figshare.9631832.v1
title: Additional file 6: of Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

description: Table S6. Prevalence, cumulative incidence, and incidence density of the risk factors (diabetes, hypertension, and dyslipidemia) for atherosclerotic cardiovascular disease in 2015 (XLSX 17 kb)
DOI: 10.6084/m9.figshare.9631814
title: Additional file 2: of Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

description: Table S2. Procedure codes and names for patients with ASCVD (XLSX 13 kb)
DOI: 10.6084/m9.figshare.9631820.v1
title: Additional file 3: of Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

description: Table S3. Medication codes to identify dyslipidemia (XLSX 11 kb)
DOI: 10.6084/m9.figshare.9631814.v1
title: Additional file 2: of Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

description: Table S2. Procedure codes and names for patients with ASCVD (XLSX 13 kb)
DOI: 10.6084/m9.figshare.9631805
title: Additional file 1: of Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

description: Table S1. Diseases, risk factors, and codes for patients with ASCVD or at a high risk for ASCVD (XLSX 11 kb)
DOI: 10.6084/m9.figshare.9631805.v1
title: Additional file 1: of Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

description: Table S1. Diseases, risk factors, and codes for patients with ASCVD or at a high risk for ASCVD (XLSX 11 kb)
DOI: 10.6084/m9.figshare.9631721
title: Additional file 9: of OsDGD2Î˛ is the Sole Digalactosyldiacylglycerol Synthase Gene Highly Expressed in Anther, and its Mutation Confers Male Sterility in Rice

description: Table S9. List of oligos and primers (XLS 49 kb)
DOI: 10.6084/m9.figshare.9631724
title: Additional file 2: of Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma

description: Figure S1. Expression of CASC9 in cell lines of other tumor entities. (a) Relative expression of CASC9 was determined by RT-qPCR across 16 urothelial carcinoma cell lines compared to the benign urothelial control cell line HBLAK and a primary urothelial cell culture (UEC). (b) Relative expression of CASC9 in prostate cancer cell lines, benign control cells (PREC, PNT-2, BPH-1) as well as normal (N) and cancerous (T) tissue. (c) Relative expression of CASC9 in testicular cancer cell lines compared to normal (N) and cancerous (T) tissue. Figure S2. Expression of a putative downstream target gene PDCD4 in HNSCC and UCC cell lines. (a) Relative expression of PDCD4 mRNA was determined by RT-qPCR across 21 HNSCC cell lines compared to benign HaCat cells. (b) Relative PDCD4 expression across 16 urothelial carcinoma cell lines compared to the benign urothelial control cell line HBLAK and a primary urothelial cell culture (UEC). (c) Relative expression of PDCD4 in cells with CASC9 overexpression or downregulation (sh). No significant changes were observed. Figure S3. Expression of a putative downstream target genes CDK4, CCND1, CDH1 and BCL2 in HNSCC cell lines. (a) Relative expression of CDK4 mRNA was determined by RT-qPCR in cell lines following CASC9 modulation and across 21 HNSCC cell lines compared to benign HaCat cells. (b) Relative expression of CCND1 mRNA was determined by RT-qPCR in cell lines following CASC9 modulation and across 21 HNSCC cell lines compared to benign HaCat cells. (c) Relative expression of E-Cadherin mRNA was determined by RT-qPCR in cell lines following CASC9 modulation and across 21 HNSCC cell lines compared to benign HaCat cells. (d) Relative expression of BCL2 mRNA was determined by RT-qPCR in cell lines following CASC9 modulation and across 21 HNSCC cell lines compared to benign HaCat cells. (ZIP 1403 kb)
DOI: 10.6084/m9.figshare.9631724.v1
title: Additional file 2: of Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma

description: Figure S1. Expression of CASC9 in cell lines of other tumor entities. (a) Relative expression of CASC9 was determined by RT-qPCR across 16 urothelial carcinoma cell lines compared to the benign urothelial control cell line HBLAK and a primary urothelial cell culture (UEC). (b) Relative expression of CASC9 in prostate cancer cell lines, benign control cells (PREC, PNT-2, BPH-1) as well as normal (N) and cancerous (T) tissue. (c) Relative expression of CASC9 in testicular cancer cell lines compared to normal (N) and cancerous (T) tissue. Figure S2. Expression of a putative downstream target gene PDCD4 in HNSCC and UCC cell lines. (a) Relative expression of PDCD4 mRNA was determined by RT-qPCR across 21 HNSCC cell lines compared to benign HaCat cells. (b) Relative PDCD4 expression across 16 urothelial carcinoma cell lines compared to the benign urothelial control cell line HBLAK and a primary urothelial cell culture (UEC). (c) Relative expression of PDCD4 in cells with CASC9 overexpression or downregulation (sh). No significant changes were observed. Figure S3. Expression of a putative downstream target genes CDK4, CCND1, CDH1 and BCL2 in HNSCC cell lines. (a) Relative expression of CDK4 mRNA was determined by RT-qPCR in cell lines following CASC9 modulation and across 21 HNSCC cell lines compared to benign HaCat cells. (b) Relative expression of CCND1 mRNA was determined by RT-qPCR in cell lines following CASC9 modulation and across 21 HNSCC cell lines compared to benign HaCat cells. (c) Relative expression of E-Cadherin mRNA was determined by RT-qPCR in cell lines following CASC9 modulation and across 21 HNSCC cell lines compared to benign HaCat cells. (d) Relative expression of BCL2 mRNA was determined by RT-qPCR in cell lines following CASC9 modulation and across 21 HNSCC cell lines compared to benign HaCat cells. (ZIP 1403 kb)
DOI: 10.6084/m9.figshare.9631721.v1
title: Additional file 9: of OsDGD2Î˛ is the Sole Digalactosyldiacylglycerol Synthase Gene Highly Expressed in Anther, and its Mutation Confers Male Sterility in Rice

description: Table S9. List of oligos and primers (XLS 49 kb)
DOI: 10.6084/m9.figshare.9631709
title: Additional file 3: of scAlign: a tool for alignment, integration, and rare cell identification from scRNA-seq data

description: Contains supplementary marker gene information. (XLS 117 kb)
DOI: 10.6084/m9.figshare.9631709.v1
title: Additional file 3: of scAlign: a tool for alignment, integration, and rare cell identification from scRNA-seq data

description: Contains supplementary marker gene information. (XLS 117 kb)
DOI: 10.6084/m9.figshare.9631703
title: Additional file 2: of scAlign: a tool for alignment, integration, and rare cell identification from scRNA-seq data

description: Contains supplementary gene ontology information. (XLS 49 kb)
DOI: 10.6084/m9.figshare.9631703.v1
title: Additional file 2: of scAlign: a tool for alignment, integration, and rare cell identification from scRNA-seq data

description: Contains supplementary gene ontology information. (XLS 49 kb)
DOI: 10.6084/m9.figshare.9631682
title: Additional file 1: of OsDGD2Î˛ is the Sole Digalactosyldiacylglycerol Synthase Gene Highly Expressed in Anther, and its Mutation Confers Male Sterility in Rice

description: Table S8. Predicted sequences features of OsDGDG proteins and annotations in various database. Accessed on 05/02/2019. (XLS 67 kb)
DOI: 10.6084/m9.figshare.9631682.v1
title: Additional file 1: of OsDGD2Î˛ is the Sole Digalactosyldiacylglycerol Synthase Gene Highly Expressed in Anther, and its Mutation Confers Male Sterility in Rice

description: Table S8. Predicted sequences features of OsDGDG proteins and annotations in various database. Accessed on 05/02/2019. (XLS 67 kb)
DOI: 10.6084/m9.figshare.9631547
title: MOESM2 of The liver proteome in a mouse model for Ascaris suum resistance and susceptibility: evidence for an altered innate immune response

description: Additional file 2: Table S4. Proteins identified from the liver left lobes of C57BL/6J and CBA/Ca mice with and without Ascaris infection. Table S5. t-test (P
DOI: 10.6084/m9.figshare.9631547.v1
title: MOESM2 of The liver proteome in a mouse model for Ascaris suum resistance and susceptibility: evidence for an altered innate immune response

description: Additional file 2: Table S4. Proteins identified from the liver left lobes of C57BL/6J and CBA/Ca mice with and without Ascaris infection. Table S5. t-test (P
DOI: 10.6084/m9.figshare.9631541
title: MOESM1 of The liver proteome in a mouse model for Ascaris suum resistance and susceptibility: evidence for an altered innate immune response

description: Additional file 1: Table S1. ANOVA statistics (P- and q-values) for all proteins (Benjamini-Hochberg FDRâ
DOI: 10.6084/m9.figshare.9631541.v1
title: MOESM1 of The liver proteome in a mouse model for Ascaris suum resistance and susceptibility: evidence for an altered innate immune response

description: Additional file 1: Table S1. ANOVA statistics (P- and q-values) for all proteins (Benjamini-Hochberg FDRâ
DOI: 10.6084/m9.figshare.9631520
title: Additional file 2: of Using a RE-AIM framework to identify promising practices in National Diabetes Prevention Program implementation

description: RE-AIM Evaluation Instrument for DP12-1212 Affiliate Sites. (XLSX 32 kb)
DOI: 10.6084/m9.figshare.9631514
title: Additional file 1: of Using a RE-AIM framework to identify promising practices in National Diabetes Prevention Program implementation

description: RE-AIM Evaluation Instrument for DP12-1212 Grantees. (XLSX 26 kb)
DOI: 10.6084/m9.figshare.9631520.v1
title: Additional file 2: of Using a RE-AIM framework to identify promising practices in National Diabetes Prevention Program implementation

description: RE-AIM Evaluation Instrument for DP12-1212 Affiliate Sites. (XLSX 32 kb)
DOI: 10.6084/m9.figshare.9631508
title: Additional file 6: of Evolution of female promiscuity in Passerides songbirds

description: The model selection approach, using AIC, to find the best multivariate PGLS model as presented in Table 2. (XLSX 13 kb)
DOI: 10.6084/m9.figshare.9631514.v1
title: Additional file 1: of Using a RE-AIM framework to identify promising practices in National Diabetes Prevention Program implementation

description: RE-AIM Evaluation Instrument for DP12-1212 Grantees. (XLSX 26 kb)